Risk factors, n (%) | Total (n = 166) | Cases, n = 83 (50%) | Controls, n = 83 (50%) | p-value | OR 95% CI | p-value | ||||
---|---|---|---|---|---|---|---|---|---|---|
Intrinsic | Â | Â | Â | Â | ||||||
Hematological status: | Â | Â | Â | Â | Â | Â | ||||
 Bone marrow transplant | 23 (13.9) | 16 (19.3) | 7 (8.4) | 0.043 | 2.59 (1.00-6.68) | 0.049 | ||||
 Febrile neutropenia | 109 (65.7) | 62 (74.7) | 47 (56.6) | 0.014 | 2.26 (1.17–4.36) | 0.015 | ||||
Comorbidities: | Â | Â | Â | Â | Â | Â | ||||
 Dementia | 6 (3.6) | 4 (4.8) | 2 (2.4) | 0.406 | 2.05 (0.36–11.51) | 0.415 | ||||
 Hypertension | 76(45.8) | 42 (50.6) | 34 (41) | 0.213 | 1.47 (0.79–2.72) | 0.213 | ||||
 Congestive Heart Failure | 34 (20.5) | 14 (16.9) | 20 (24.1) | 0.249 | 0.63 (0.29–1.37) | 0.251 | ||||
 Chronic Obstructive Pulmonary Disease | 11 (6.6) | 1 (1.2) | 10 (12) | 0.005 | 0.08 (0.01–0.71) | 0.023 | ||||
 Peptic ulcer disease | 16 (9.6) | 12 (14.5) | 4 (4.8) | 0.035 | 3.33 (1.02–10.82) | 0.045 | ||||
 Liver disease | 40 (24.1) | 22 (26.5) | 18 (21.7) | 0.468 | 1.37 (0.66–2.84) | 0.384 | ||||
 Diabetes Mellitus | 25 (15.1) | 12 (14.5) | 13 (15.7) | 0.828 | 0.91 (0.38–2.13) | 0.828 | ||||
 Chronic Kidney Disease | 10 (6.0) | 4 (4.8) | 6 (7.2) | 0.514 | 0.80 (0.42–1.54) | 0.517 | ||||
 Peripheral Vascular Disease | 64 (40.4) | 34 (41) | 30 (36) | 0.874 | 1.05 (0.56–1.95) | 0.874 | ||||
 Solid Tumor | 19 (11.4) | 6 (7.2) | 13 (15.7) | 0.088 | 0.64 (0.38–1.07) | 0.095 | ||||
 Solid transplant | 4 (2.4) | 2 (2.4) | 2 (2.4) | 1.000 | 1.0 (0.13–7.27) | 1.000 | ||||
Other predisposing factors to colonization | Â | Â | Â | Â | Â | Â | ||||
 Cachexia or weight loss | 26 (15.7) | 18 (21.7) | 8 (9.6) | 0.033 | 2.59 (1.05–6.36) | 0.037 | ||||
 Reduced mobility | 41 (24.7) | 27 (32.5) | 14 (16.9) | 0.019 | 2.37 (1.13–4.95) | 0.021 | ||||
 Altered bowel habits | 93 (56.0) | 59 (71.1) | 34 (41) | < 0.001 | 3.54 (1.85–6.75) | < 0.001 | ||||
Colonization status: | Â | Â | Â | Â | Â | Â | ||||
MDR pathogens: | 37 (22.3) | 18 (21.7) | 19 (22.9) | 0.852 | Â | Â | ||||
 XDR P. aeruginosa | 9 (5.4) | 4 (4.8) | 5 (6) | 0.775 | 0.78 (0.20–3.05) | 0.732 | ||||
E. coli ESBL+ | 6 (3.6) | 4 (4.8) | 2 (2.4) |  | 1.47 (0.24–9.11) | 0.673 | ||||
 CPE | 3 (1.8) | 1 (1.2) | 2 (2.4) |  | 1.97 (0-17-22.23) | 0.582 | ||||
 CRAB | 1 (0.6) | 0 (0.0) | 1 (1.2) |  | 1 (empty) |  | ||||
 MRSA | 1 (0.6) | 0 (0.0) | 1 (1.2) |  | 1 (empty) |  | ||||
Extrinsic | Â | Â | Â | Â | Â | Â | ||||
Presence of an invasive device/intervention: | ||||||||||
 Pacemaker | 3 (1.8) | 1 (1.2) | 2 (2.4) | 0.560 | 0.49 (0.04–5.55) | 0.568 | ||||
 Prosthesis/stent | 13 (7.8) | 3 (3.6) | 10 (12) | 0.043 | 0.27 (0.07–1.03) | 0.056 | ||||
 Central venous catheter | 138 (83.1) | 78 (94) | 60 (72.3) | < 0.001 | 5.97 (2.14–16.65) | 0.001 | ||||
 Tracheostomy | 5 (3.0) | 3 (3.6) | 2 (2.4) | 0.650 | 1.51 (0.24–9.33) | 0.652 | ||||
 Urinary catheter | 66 (39.8) | 38 (45.8) | 28 (33.7) | 0.113 | 1.65 (0.88–3.10) | 0.114 | ||||
 Non-abdominal surgery (\(\le\)6 months) | 21 (12.7) | 14 (16.9) | 7 (8.4) | 0.102 | 2.20 (0.84–5.77) | 0.108 | ||||
 Surgical wounds/ pressure ulcers | 48 (28.9) | 34 (41.0) | 14 (16.9) | 0.001 | 3.41 (1.66–7.04) | 0.001 | ||||
 Abdominal surgery (\(\le\)6 months) | 84 (50.6) | 44 (53.0) | 40 (48.2) | 0.535 | 1.21 (0.65–2.23) | 0.535 |